Cargando…

Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study

OBJECTIVES: Haemolytic uraemic syndrome (HUS) following Shiga toxin-producing Escherichia coli (STEC) infection is the the most common cause of acute renal failure among children in the UK. This study explored differential progression from STEC to HUS by social, demographic and clinical risk factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, Natalie, Byrne, Lisa, Rose, Tanith, Adak, Bob, Jenkins, Claire, Charlett, Andre, Violato, Mara, O'Brien, Sarah, Whitehead, Margaret, Barr, Benjamin, Taylor-Robinson, David, Hawker, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936988/
https://www.ncbi.nlm.nih.gov/pubmed/31909217
http://dx.doi.org/10.1136/bmjpo-2019-000465
_version_ 1783483798682337280
author Adams, Natalie
Byrne, Lisa
Rose, Tanith
Adak, Bob
Jenkins, Claire
Charlett, Andre
Violato, Mara
O'Brien, Sarah
Whitehead, Margaret
Barr, Benjamin
Taylor-Robinson, David
Hawker, Jeremy
author_facet Adams, Natalie
Byrne, Lisa
Rose, Tanith
Adak, Bob
Jenkins, Claire
Charlett, Andre
Violato, Mara
O'Brien, Sarah
Whitehead, Margaret
Barr, Benjamin
Taylor-Robinson, David
Hawker, Jeremy
author_sort Adams, Natalie
collection PubMed
description OBJECTIVES: Haemolytic uraemic syndrome (HUS) following Shiga toxin-producing Escherichia coli (STEC) infection is the the most common cause of acute renal failure among children in the UK. This study explored differential progression from STEC to HUS by social, demographic and clinical risk factors. METHODS: We undertook a retrospective cohort study linking two datasets. We extracted data on paediatric STEC and HUS cases identified in the Public Health England National Enhanced Surveillance System for STEC and British Paediatric Surveillance Unit HUS surveillance from 1 October 2011 to 31 October 2014. Using logistic regression, we estimated the odds of HUS progression by risk factors. RESULTS: 1059 paediatric STEC cases were included in the study, of which 207 (19.55%, 95% CI 17% to 22%) developed HUS. In the fully adjusted model, the odds of progression to HUS were highest in those aged 1–4 years (OR 4.93, 95% CI 2.30 to 10.56, compared with 10–15 years), were infected with an Shiga toxin (stx) 2-only strain (OR 5.92, 95% CI 2.49 to 14.10), were prescribed antibiotics (OR 8.46, 95% CI 4.71 to 15.18) and had bloody diarrhoea (OR 3.56, 95% CI 2.04 to 6.24) or vomiting (OR 4.47, 95% CI 2.62 to 7.63), but there was no association with progression to HUS by socioeconomic circumstances or rurality. CONCLUSION: Combining data from an active clinical surveillance system for HUS with the national enhanced STEC surveillance system suggests that 20% of diagnosed paediatric STEC infections in England resulted in HUS. No relationship was found with socioeconomic status or rurality of cases, but differences were demonstrated by age, stx type and presenting symptoms.
format Online
Article
Text
id pubmed-6936988
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-69369882020-01-06 Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study Adams, Natalie Byrne, Lisa Rose, Tanith Adak, Bob Jenkins, Claire Charlett, Andre Violato, Mara O'Brien, Sarah Whitehead, Margaret Barr, Benjamin Taylor-Robinson, David Hawker, Jeremy BMJ Paediatr Open Epidemiology OBJECTIVES: Haemolytic uraemic syndrome (HUS) following Shiga toxin-producing Escherichia coli (STEC) infection is the the most common cause of acute renal failure among children in the UK. This study explored differential progression from STEC to HUS by social, demographic and clinical risk factors. METHODS: We undertook a retrospective cohort study linking two datasets. We extracted data on paediatric STEC and HUS cases identified in the Public Health England National Enhanced Surveillance System for STEC and British Paediatric Surveillance Unit HUS surveillance from 1 October 2011 to 31 October 2014. Using logistic regression, we estimated the odds of HUS progression by risk factors. RESULTS: 1059 paediatric STEC cases were included in the study, of which 207 (19.55%, 95% CI 17% to 22%) developed HUS. In the fully adjusted model, the odds of progression to HUS were highest in those aged 1–4 years (OR 4.93, 95% CI 2.30 to 10.56, compared with 10–15 years), were infected with an Shiga toxin (stx) 2-only strain (OR 5.92, 95% CI 2.49 to 14.10), were prescribed antibiotics (OR 8.46, 95% CI 4.71 to 15.18) and had bloody diarrhoea (OR 3.56, 95% CI 2.04 to 6.24) or vomiting (OR 4.47, 95% CI 2.62 to 7.63), but there was no association with progression to HUS by socioeconomic circumstances or rurality. CONCLUSION: Combining data from an active clinical surveillance system for HUS with the national enhanced STEC surveillance system suggests that 20% of diagnosed paediatric STEC infections in England resulted in HUS. No relationship was found with socioeconomic status or rurality of cases, but differences were demonstrated by age, stx type and presenting symptoms. BMJ Publishing Group 2019-12-17 /pmc/articles/PMC6936988/ /pubmed/31909217 http://dx.doi.org/10.1136/bmjpo-2019-000465 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
Adams, Natalie
Byrne, Lisa
Rose, Tanith
Adak, Bob
Jenkins, Claire
Charlett, Andre
Violato, Mara
O'Brien, Sarah
Whitehead, Margaret
Barr, Benjamin
Taylor-Robinson, David
Hawker, Jeremy
Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study
title Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study
title_full Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study
title_fullStr Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study
title_full_unstemmed Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study
title_short Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study
title_sort sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936988/
https://www.ncbi.nlm.nih.gov/pubmed/31909217
http://dx.doi.org/10.1136/bmjpo-2019-000465
work_keys_str_mv AT adamsnatalie sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy
AT byrnelisa sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy
AT rosetanith sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy
AT adakbob sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy
AT jenkinsclaire sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy
AT charlettandre sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy
AT violatomara sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy
AT obriensarah sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy
AT whiteheadmargaret sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy
AT barrbenjamin sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy
AT taylorrobinsondavid sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy
AT hawkerjeremy sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy